Rate My Professor Cherie Stayner

In addition to her research role, Stayner is the Research Manager at the Edgar Diabetes and Obesity Research (EDOR) centre in the Department of Medicine, where she coordinates research activities, grant applications, publication efforts, public events, media responses, and collaborations. This position leverages her expertise in renal disease to support broader initiatives on diabetes prevention, obesity policy, and health equity through co-design approaches in Aotearoa New Zealand. Key publications include 'Recent Discoveries in Epigenetic Modifications of Polycystic Kidney Disease' (International Journal of Molecular Sciences, 2021), 'Chemical Synthesis of the PAX Protein Inhibitor EG1 and Its Ability to Slow the Growth of Human Colorectal Carcinoma Cells' (Frontiers in Oncology, 2021), 'Extensive Inter-Cyst DNA Methylation Variation in Autosomal Dominant Polycystic Kidney Disease Revealed by Genome Scale Sequencing' (Frontiers in Genetics, 2020), 'Targeted Therapies for Autosomal Dominant Polycystic Kidney Disease' (Current Medicinal Chemistry, 2019), and 'Rapamycin-Mediated Suppression of Renal Cyst Expansion in an Orthologous Polycystic Kidney Disease Model' (Human Molecular Genetics, 2012). With approximately 464 citations across 29 publications, her contributions influence therapeutic strategies for polycystic kidney diseases.